Skip to main content
SpringerLink
Log in

Surgery for Advanced Gastric Cancer

  • Chapter
Book cover The Diversity of Gastric Carcinoma

Conclusion

These extensive or superextensive surgical procedures for advanced cancer represent an attempt to increase the cure rate. The survival benefit, however, is limited, and the surgical procedure should be carefully selected for each patient. Adjuvant chemotherapy represents another attempt to treat advanced gastric cancer, and further investigation is required.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Maruyama K, Sasako M, Kinoshita T, et al (1993) Effectiveness of systematic lymph node dissection in gastric surgery. In: Nishi M, Ichikawa H, Nakajima T, Maruyama K, Tahara E (eds). Gastric cancer. Springer, Berlin, pp 293–305

    Google Scholar 

  2. Akoh JA, Macintyre IM (1992) Improving survival in gastric cancer review of 5-year survival rates in English publications from 1970. Br J Surg 79:293–299

    CAS  PubMed  Google Scholar 

  3. Wanebo HJ, Kennedy BJ, Chmiel J, et al (1993) Cancer of the stomach: a patient care study by the American College of Surgeons. Ann Surg 218:583–592

    CAS  PubMed  Google Scholar 

  4. Japanese Gastric Cancer Association, Registration Committee (2003) Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer 6(suppl): 1–14

    Google Scholar 

  5. Bunt A, Herman J, Smit V, et al (1995) Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rate between Japan and Western countries. J Clin Oncol 13:19–25

    CAS  PubMed  Google Scholar 

  6. Fuchs CS, Mayer RJ (1995) Gastric carcinoma. N Engl J Med 333:32–41

    CAS  PubMed  Google Scholar 

  7. Diggory MT, Cuschieri A (1985) R2/3 gastrectomy for gastric carcinoma: an audited experience of a consecutive series. Br J Surg 72:146–148

    CAS  PubMed  Google Scholar 

  8. Dent DM, Madden MV, Price SK (1988) Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 75:110–112

    CAS  PubMed  Google Scholar 

  9. Pacelli F, Doglietto GB, Bellantone R, et al (1993) Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg 80:1153–1156

    CAS  PubMed  Google Scholar 

  10. Siewert JR, Bottcher K, Roder JD, et al (1993) Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg 80: 1015–1018

    CAS  PubMed  Google Scholar 

  11. Bonenkamp JJ, Hermans J, Sasako M, et al (1999) Extended lymph node dissection for gastric cancer. N Engl J Med 340:908–914

    Article  CAS  PubMed  Google Scholar 

  12. Cuschieri A, Weeden S, Fielding J, et al (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Cooperative Group. Br J Cancer 79:1522–1530

    Article  CAS  PubMed  Google Scholar 

  13. Schmidt-Matthiesen A (1998) Should systematic lymph node dissection be recommended for gastric cancer? Contra. Eur J Cancer 34:1483–1486

    Google Scholar 

  14. Sasako M (2004) Role of surgery in multidisciplinary treatment for solid cancers. Int J Clin Oncol 9:346–351

    Article  PubMed  Google Scholar 

  15. Bonenkamp JJ, Songun I, Hermans J, et al (1995) Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345:745–748

    Article  CAS  PubMed  Google Scholar 

  16. Cuschieri A, Fayers P, Fielding J, et al (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomized controlled surgical trial. Lancet 347:995–999

    Article  CAS  PubMed  Google Scholar 

  17. Sano T, Sasako M, Yamamoto S, et al (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy—Japan Clinical Oncology Group study 9501. J Clin Oncol 22:2767–2773

    Article  PubMed  Google Scholar 

  18. Moriwaki Y, Kunisaki C, Kobayashi S, et al (2003) Does body mass index (BMI) influence morbidity and long-term survival in gastric cancer patients after gastrectomy? Hepatogastroenterology 50:284–288

    PubMed  Google Scholar 

  19. Gretschel S, Christoph F, Bembenek A, et al (2003) Body mass index does not affect systematic D2 lymph node dissection and post operative morbidity in gastric cancer patients. Ann Surg Oncol 10:363–368

    Article  PubMed  Google Scholar 

  20. Sasako M, McCulloch P, Kinoshita T, et al (1995) New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 82:346–351

    CAS  PubMed  Google Scholar 

  21. Siewert JR, Bottcher K, Stein HJ, et al (1998) Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228:449–461

    Article  CAS  PubMed  Google Scholar 

  22. Kooby DA, Suriawinata A, Klimstara DS, et al (2003) Biologic predictors of survival in nodenegative gastric cancer. Ann Surg 237:828–837

    PubMed  Google Scholar 

  23. Maruyama K, Sasako M, Kinishita T, et al (1998) Should systemic lymph node dissection be recommended for gastric cancer? pro. Eur J Cancer 34:1480–1483

    Article  CAS  PubMed  Google Scholar 

  24. Kasakura Y, Mochizuki F, Wakabayashi K, et al (2002) An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution. J Surg Res 103:252–259

    Article  PubMed  Google Scholar 

  25. Roukos DH, Lorenz M, Encke A (1998) Evidence of survival benefit of extended (D2) lymphadenectomy in Western patients with gastric cancer based on a new concept. A prospective long-term follow-up study. Surgery (St. Louis) 123:573–578

    Article  CAS  PubMed  Google Scholar 

  26. Harrison LE, Karpeh MS, Brennan MF (1998) Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer. J Gastrointest Surg 2:126–131

    Article  CAS  PubMed  Google Scholar 

  27. Smith JW, Shiu MH, Kelsey L, et al (1991) Morbidity of radical lymphadenectomy in curative resection of gastric carcinoma. Arch Surg 126:1469–1473

    CAS  PubMed  Google Scholar 

  28. Sue-Ling HM, Johnston D, Martin IG, et al (1993) Gastric cancer: a curable disease in Britain. Br J Surg 307:591–596

    CAS  Google Scholar 

  29. Birkmeyer JD, Stukel TA, Siewers AE, et al (2003) Surgeon volume and operative mortality in the United States. New Engl J Med 349:2117–2127

    Article  CAS  PubMed  Google Scholar 

  30. Fujita T, Yamazaki Y (2002) Influence of surgeon’s volume on early outcome after total gastrectomy. Eur J Surg 168:535–538

    PubMed  Google Scholar 

  31. Perikh D, Johnson M, Chagla L, et al (1996) D2 gastrectomy lessons from a prospective audit of the learning curve. Br J Surg 83:1595–1599

    Google Scholar 

  32. Moriwaki Y, Kobayashi S, Kunisaki C, et al (2001) Is D2 lymphadenectomy in gastrectomy safe with regard to the skill of the operator? Dig Surg 18:111–117

    Article  CAS  PubMed  Google Scholar 

  33. Degiuli M, Sasako M, Ponti A, et al (1998) Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study. J Clin Oncol 16(4):1490–1493

    CAS  PubMed  Google Scholar 

  34. Degiuli M, Sasako M, Ponti A, et al (2004) Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 90(9):1727–1732

    CAS  PubMed  Google Scholar 

  35. Takahashi S (1990) Study of para-aortic lymph node metastases of gastric cancer subjected to superextensive lymph node dissection (in Japanese with English abstract). J Jpn Surg Soc (Nippon Geka Gakkai Zasshi) 91:29–35

    CAS  Google Scholar 

  36. Kitamura M, Arai K, Iwasaki Y (1996) Clinicopathological studies and problems on paraaortic lymph node dissection: D4 dissection (in Japanese with English abstract). J Jpn Surg Soc (Nippon Geka Gakkai Zasshi) 97:302–307

    CAS  Google Scholar 

  37. Isozaki H, Okajima K, Fujii K, et al (1999) Effectiveness of paraaortic lymph node dissection for advanced gastric cancer. Hepatogastroenterology 46:549–554

    CAS  PubMed  Google Scholar 

  38. Baba M, Hokita S, Natsugoe S, et al (1999) Paraaortic lymphadenectomy in patients with advanced carcinoma of the upper-third of the stomach. Hepatogastroenterology 47:893–896

    Google Scholar 

  39. Ohashi I, Takagi K, Konishi T, et al (1976) Five-year survival of patients with dissection of paraaortic lymph node metastases for gastric cancer (in Japanese with English abstract). Jpn J Gastroenterol Surg 9:112–116

    Google Scholar 

  40. Yonemura Y, Hashimoto T, Katayama K, et al (1985) Classification of paraaortic lymph nodes and significance of dissection of these nodes in gastric cancer (in Japanese with English abstract). Jpn J Gastroenterol Surg 18:1995–1999

    Google Scholar 

  41. Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer 1:10–24

    Article  PubMed  Google Scholar 

  42. Sano T, Sasako M, Yamamoto S, et al (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended paraaortic lymphadenectomy—Japan Clinical Oncology Group Study 9501. J Clin Oncol 22: 2767–2773

    Article  PubMed  Google Scholar 

  43. Shimoyama S, Mafune K, Kaminishi M (2005) Safety of a paraaortic node dissection for selected advanced gastric cancer patients. Hepatogastnoenterology (in press)

    Google Scholar 

  44. Maeta M, Yamashiro H, Saito H, et al (1999) A prospective pilot study of extended (D3) and super extended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy. Surgery (St. Louis) 125:325–331

    CAS  PubMed  Google Scholar 

  45. Appleby LH (1953) The celiac axis in the expansion of the operation for gastric carcinoma. Cancer (Phila) 6:704–707

    CAS  PubMed  Google Scholar 

  46. Takagi K (1990) Extended operation (in Japanese). Gastroenterol Surg 13:789

    Google Scholar 

  47. Hiratsuka M, Furukawa H (2003) Application of left upper abdominal extentration. In: Arai K (ed) Knack and pitfalls of gastric surgery (in Japanese). Bunkodo, Tokyo, pp 109–111

    Google Scholar 

  48. Furukawa H, Hiratsuka M, Iwanaga T, et al (1997) Extended surgery—left upper abdominal extenteration plus Appleby’s method—for type 4 gastric carcinoma. Ann Surg Oncol 4: 209–214

    Article  CAS  PubMed  Google Scholar 

  49. Hulscher JB, van Sandick JW, de Boer AG, et al (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347:1662–1669

    Article  PubMed  Google Scholar 

  50. Sasako M, Sano T, Sairenji M, et al (2004) Left thorac-abdomonal approach (LT) compared with abdominal and transhiatal approach (AT) for cardia or sub-cardia cancer. Results of a surgical randomized controlled trial (JCOG 9502). J Clin Oncol 22:314s

    Google Scholar 

  51. Oyama S, Yamaguchi T (2003) Application of pancreatoduodenectomy. In: Arai K (ed) Knack and pitfalls of gastric surgery (in Japanese). Bunkodo, Tokyo, pp 112–115

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastrointestinal Surgery, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan

    Ken-ichi Mafune

Authors
  1. Ken-ichi Mafune
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Gastrointestinal Surgery, Surgical Metabolic Care and Endocrine Surgery, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan

    Michio Kaminishi M.D., Ph.D.

  2. Human Tissue Research Group, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakaecho, Itabashi-ku, Tokyo, 173-0015, Japan

    Kaiyo Takubo M.D., Ph.D.

  3. Department of Gastrointestinal Surgery, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan

    Ken-ichi Mafune M.D., Ph.D., F.A.C.S.

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Tokyo

About this chapter

Cite this chapter

Mafune, Ki. (2005). Surgery for Advanced Gastric Cancer. In: Kaminishi, M., Takubo, K., Mafune, Ki. (eds) The Diversity of Gastric Carcinoma. Springer, Tokyo. https://doi.org/10.1007/4-431-27713-7_20

Download citation

  • DOI: https://doi.org/10.1007/4-431-27713-7_20

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-21139-6

  • Online ISBN: 978-4-431-27713-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation